| EX1095 IMMUNOHISTOCHEMISTRY: ALKD5F3 |
| Specimen: |
Submit Tissue in 10% formal-saline OR formalin-fixed paraffin-embedded Tissue Block. Ship at room temperature. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| NA |
NA |
NA |
|
| Method: |
IHC |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
ALKD5F3 detects eligibility for Tyrosine kinase inhibitor (TKI) therapy primarily in individuals with pulmonary adenocarcinoma by identifying ALK fusion proteins. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Cancer |
| Components: |
|
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Histopathology |
| Pre Test Information: |
Provide a copy of the Histopathology report, Site of biopsy, and Clinical history. |
Reviews
There are no reviews yet.